Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration – (Eye 29, 1141 (September 2015))
Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration Eye 29, 1141 (September 2015). doi:10.1038/eye.2015.131 Authors: H S Kim, H J Cho, S G Yoo, J H Kim, J I Han, T G Lee & J W Kim
Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results – (Eye 29, 1152 (September 2015))
Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results Eye 29, 1152 (September 2015). doi:10.1038/eye.2015.87 Authors: N Homer, D S Grewal, R G Mirza, A T Lyon & M K Gill
Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland – (Eye 29, 1156 (September 2015))
Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland Eye 29, 1156 (September 2015). doi:10.1038/eye.2015.83 Authors: S Borooah, V S Jeganathan, A-M Ambrecht, D Oladiwura, M Gavin, B Dhillon & P Cackett
A 10-year review of orbital biopsy: the Newcastle Eye Centre Study – (Eye 29, 1162 (September 2015))
A 10-year review of orbital biopsy: the Newcastle Eye Centre Study Eye 29, 1162 (September 2015). doi:10.1038/eye.2015.95 Authors: D S J Ting, M Perez-Lopez, N J Chew, L Clarke, A J Dickinson & C Neoh
Cup-to-disc and arteriole-to-venule ratios in preterm birth – (Eye 29, 1167 (September 2015))
Cup-to-disc and arteriole-to-venule ratios in preterm birth Eye 29, 1167 (September 2015). doi:10.1038/eye.2015.99 Authors: J Kim, D Y Choi, K-A Park & S Y Oh